DUBLIN — Research and Markets has announced the addition of the "Systemic Lupus Erythematosus - Pipeline Review, H1 2013" report to their offering.
Global Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Lupus Erythematosus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Lupus Erythematosus.
- A review of the Systemic Lupus Erythematosus products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Via: Kcentra Approved to Stop Severe Bleeding in Heart Patients
No comments:
Post a Comment